|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,938.70 INR | +2.67% |
|
+3.62% | +12.73% |
| 06-25 | Jefferies quarterly profit misses estimates as asset management weighs | RE |
| 06-25 | Jefferies quarterly profit more than doubles on dealmaking, equities strength | RE |
| Market Cap | 4,530B 47.31B 41.5B 38.31B 35.4B 67.11B 68.45B 461B 179B 2,217B 178B 174B 7,696B | P/E 2027 * |
34.5x | P/E 2028 * | 29.2x |
|---|---|---|---|---|---|
| Enterprise Value | 4,257B 44.46B 39B 36B 33.27B 63.06B 64.32B 433B 168B 2,083B 167B 163B 7,232B | EV / Sales 2027 * |
6.51x | EV / Sales 2028 * | 5.74x |
| Free-Float |
44.39% | Yield 2027 * |
0.84% | Yield 2028 * | 0.94% |
Last Transcript: Sun Pharmaceutical Industries Ltd.
| 1 day | +2.67% | ||
| 1 week | +3.62% | ||
| Current month | +4.09% | ||
| 1 month | +8.98% | ||
| 3 months | +12.91% | ||
| 6 months | +12.07% | ||
| Current year | +12.73% |
| 1 week | 1,871.6 |  | 1,952 |
| 1 month | 1,771 | | 1,952 |
| Current year | 1,583.7 | | 1,952 |
| 1 year | 1,548 | | 1,952 |
| 3 years | 1,031.1 | | 1,960.35 |
| 5 years | 666.4 | | 1,960.35 |
| 10 years | 312 | | 1,960.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Chief Executive Officer | 59 | 01/09/2025 | |
| Director of Finance/CFO | 58 | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
| Director/Board Member | 59 | 01/09/2025 | |
| Director/Board Member | 73 | 25/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.67% | +3.62% | +16.13% | +85.52% | 47.31B | |
| -0.81% | -4.53% | +65.57% | +113.67% | 36.04B | |
| +0.66% | -1.01% | -3.38% | +41.76% | 12.08B | |
| +0.96% | +5.38% | +18.45% | +99.28% | 11.96B | |
| +0.38% | +1.95% | +34.36% | +123.93% | 9.05B | |
| +0.58% | -0.25% | +17.85% | +44.67% | 6.92B | |
| -1.61% | +1.96% | +54.90% | -2.70% | 7.19B | |
| +1.96% | +3.24% | +24.65% | +241.55% | 6.55B | |
| -7.00% | +5.26% | -20.00% | +10.09% | 5.9B | |
| +0.88% | -1.13% | +25.90% | +135.15% | 4.28B | |
| Average | -0.13% | +1.32% | +23.44% | +89.29% | 14.73B | |
| Weighted average by Cap. | +0.60% | +1.99% | +29.13% | +91.43% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 654B 6.83B 5.99B 5.53B 5.11B 9.69B 9.88B 66.5B 25.84B 320B 25.66B 25.09B 1,111B | 729B 7.62B 6.68B 6.17B 5.7B 10.8B 11.02B 74.15B 28.81B 357B 28.61B 27.98B 1,239B |
| Net income | 133B 1.38B 1.21B 1.12B 1.04B 1.96B 2B 13.48B 5.24B 64.89B 5.2B 5.09B 225B | 157B 1.64B 1.43B 1.32B 1.22B 2.32B 2.37B 15.92B 6.18B 76.62B 6.14B 6.01B 266B |
| Net Debt | -273B -2.85B -2.5B -2.31B -2.14B -4.05B -4.13B -27.77B -10.79B -134B -10.71B -10.48B -464B | -341B -3.57B -3.13B -2.89B -2.67B -5.06B -5.16B -34.72B -13.49B -167B -13.39B -13.1B -580B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | ₹1,938.70 | +2.67% | 4,445,957 |
| 08/07/26 | ₹1,888.20 | -0.80% | 2,785,926 |
| 07/07/26 | ₹1,903.40 | -0.49% | 2,060,613 |
| 06/07/26 | ₹1,912.80 | +0.42% | 1,213,635 |
| 03/07/26 | ₹1,904.80 | +1.81% | 2,168,491 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUNPHARMA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
